cro.directory
← Compare landing

Protheragen vs Southern Research

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/obesityscientific/southernresearch

CategoryProtheragenSouthern Research
Listed sitecrocro
SummarySpecialized preclinical CRO dedicated to obesity research, offering comprehensive animal models, pharmacokinetic/pharmacodynamic studies, bioanalysis, and safety assessment for anti-obesity drug development.Leading contract research organization offering preclinical and clinical research services across infectious disease, oncology, and rare diseases, with specialized capabilities in bioanalytical labs, BSL-3 facilities, and in vivo models.
Services
  • In Vivo PK / PD Studies
  • In Vivo Efficacy Models
  • Preclinical In Vivo Studies
  • Safety Pharmacology
  • GLP Toxicology
  • Bioanalysis
  • LC-MS Bioanalysis (Small Molecule)
  • Specialized & Large-Animal Models
  • Target Identification & Validation
  • Medicinal Chemistry
  • Regulatory Affairs
  • Medical Writing
  • Clinical Operations
  • Biostatistics & Statistical Programming
  • Data Management & eClinical
  • Pharmacovigilance & Drug Safety
  • Discovery Research
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • Preclinical In Vitro Studies
  • Ligand-Binding Bioanalysis (Large Molecule)
  • US FDA Regulatory Strategy
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Trial Services
  • Discovery Research
  • High-Throughput Screening
  • Medicinal Chemistry
  • In Vitro ADME / DMPK
  • Safety Pharmacology
  • In Vivo PK / PD Studies
  • In Vivo Efficacy Models
  • Preclinical In Vivo Studies
  • Specialized & Large-Animal Models
  • GLP Toxicology
  • Pathology & Histology Services
  • Bioanalysis
  • Clinical Trial Services
Modalities
  • Small Molecule
  • Gene Therapy
  • Cell Therapy
  • Biologics (Monoclonal Antibodies)
  • Peptide
Data not yet provided.
Indications
  • Metabolic
  • Oncology
  • Infectious Disease
  • Rare Disease
LocationsData not yet provided.
  • Headquarters, Birmingham, Alabama, United States
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.